The Ministry of Health, Labor and Welfare (MHLW) has issued a notification outlining the intent and key elements of amendments to the Pharmaceuticals and Medical Devices (PMD) Act, which are set to take effect on May 1. Dated December 26,…
To read the full story
Related Article
- MHLW Clarifies Use of Real-World Data in Drug Applications
March 5, 2026
- MHLW Issues 15 Notices Ahead of PMD Act Amendment
March 2, 2026
- Japan’s Parliament Enacts Bill to Amend PMD Act
May 15, 2025
REGULATORY
- Japan to Designate International Clinical Trial Hubs in FY2027
August 28, 2026
- MHLW Tax Reform Requests Cover Support for MCM Preparedness
August 28, 2026
- Patient Group Flags Risks of Inconsistent Decisions on OTC-Like Drug Charges
August 28, 2026
- MHLW Pharma Bureau Eyes 12 Billion Yen to Boost Plasma Product Production
August 28, 2026
- Novo, Lilly Want Reimbursement Support for Obesity Care: LDP Hearing
August 28, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





